Jubilant Pharmova Ltd. (JUBLPHARMA)
Market Closed
10 Aug, 10:00
XNSE XNSE Primary MSE ₹
962. 70
+30.7
+3.294%
₹
136.25B Market Cap
274.27 P/E Ratio
20% Div Yield
357,542 Volume
0 Eps
₹ 932
Previous Close Want to track JUBLPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jubilant Pharmova Ltd. (JUBLPHARMA) Statistics
Valuation metrics
Market Cap 136.25B
Enterprise value 171.09B
Trailing P/E (ttm) 37.04
Forward P/E 23.69
PEG ratio -0.71
Price/Sales (ttm) 1.78
Price/Book (mrq) 2.08
Enterprise Value/Revenue 2.07
Enterprise Value/EBITDA 13.7
Overview
Shares outstanding 158.37M
Float 63.53M
Shares short -
% Held by insiders 0.58%
% Held by institutions 0.21%
Average volume (10 days) 133.97K
Average volume (90 days) 124.15K
Price summary
52-Week low 786.05
52-Week high 1,184.8
Beta 0.48
50-Day moving average 970.89
200-Day moving average 935.85
Dividends and splits
Forward annual dividend rate 20
Forward annual dividend yield 0.0237%
Trailing annual dividend rate 5
Trailing annual dividend yield 0.0054%
5-Year annual dividend yield 0.7%
Payout ratio 0.2
Dividend Date 24 Jul 2026
Ex-Dividend Date 24 Jul 2026
Last split factor 21:20
Last split Date 25 Nov 2010
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.05%
Operating margin 0.16%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.06%
Income Statement
Revenue (ttm) 79.18B
Revenue per share (ttm) 523.54
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 51.43B
EBITDA 12.47B
Net income to common (ttm) 4.33B
Diluted EPS (ttm) 25.2
Quarterly earnings growth (yoy) -0.45%
Balance Sheet
Total cash (mrq) 6.23B
Total cash per share (mrq) 80.15
Total debt (mrq) 28.83B
Total Debt/Equity (mrq) 0.51
Current ratio (mrq) 1.62%
Book value per share (mrq) 448.67
Cash Flow
Cash flow statement 8.86B
Levered free cash flow (LFCF) 8.39B
